CryoPort Introduces High-Volume Dry Shipping Container

Expanded Capacity Addresses Needs of Life Science Customers

SAN DIEGO--(BUSINESS WIRE)-- CryoPort, Inc. (OTCBB:CYRX) today announced it is increasing its line of deep frozen shipping containers with the introduction of the CryoPort Express® high-volume dry vapor liquid nitrogen shipper. The new shipping container can accommodate much larger shipments of cryogenically frozen biological materials.

“The CryoPort Express high-volume shipper creates new market opportunities by providing pharmaceutical companies, CROs and diagnostic labs the option of increasing the size of each shipment or shipping larger specimens,” said Larry Stambaugh, CryoPort’s chairman and chief executive officer. “This new shipper was in response to demand by customers who were impressed with the performance of the CryoPort standard shipping container and were looking for the same capabilities when making larger shipments. I’m very pleased with the effort and achievement of our design and manufacturing team in developing the high-volume dry shipper in a relatively short time frame.”

Similar to CryoPort’s standard shipper, the new high-volume container is based on the company’s proprietary dry vapor technology, utilizing liquid nitrogen in an absorbent material that provides extended endurance of below -150^oC for 10 days. The high-volume liquid nitrogen dry shipper is completely reusable and recyclable, making it highly sustainable and cost effective for transporting life science materials. The high-volume liquid nitrogen dry shipper can store up to five 5”x5”x2” cryovial boxes, or six Tyvek bags for shipments from 450 up to 500 vials.

The Company has begun making shipments with the new high-volume container this month for selected customers who expressed the initial desire for this capability.

About CryoPort, Inc.

CryoPort provides leading edge cold chain logistics services through the combination of purpose built proprietary technologies and total turnkey management of the entire process. The CryoPort Express liquid nitrogen based dry vapor shipper is validated to maintain a constant -150°C temperature for a minimum 10-day dynamic shipment duration, and its CryoPortal Logistics Management Platform manages the entire shipment process, including initial order, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. CryoPort’s total turnkey service management approach offers reliability, cost effectiveness, and convenience, while the use of recyclable and reuseable components provides a “green” and environmentally friendly solution. For more information visit www.cryoport.com and the Cold Chain Transport blog at http://www.cryoport.com/biological-shipping-blog/

Forward Looking Statements

Statements in this press release which are not purely historical, including statements regarding CryoPort, Inc.’s intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, and technical development risks. The company’s business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended March 31, 2011. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. CryoPort, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

LHA
Don Markley
310-691-7100
dmarkley@lhai.com

Source: CryoPort, Inc.

Released January 11, 2012